title: Autoantibodies typical of non-organ-specific autoimmune diseases in HIV-seropositive patients.
abstract: OBJECTIVE
  To analyse serological aspects of systemic autoimmunity in HIV-1-seropositive patients and in individuals at risk for AIDS.
  
  
  METHODS
  The reactivity of antibodies in the serum of 100 HIV-1-seropositive patients was investigated by enzyme-linked immunosorbent assay (ELISA) using a series of antigens known to be recognized by antibodies from patients with multisystemic autoimmune diseases, such as systemic lupus erythematosus, mixed-connective tissue disease and Sjögren's syndrome.
  
  
  RESULTS
  High levels of immunoglobulin G (IgG) antibodies reacting with double-stranded DNA (dsDNA), synthetic peptides of ubiquitinated histone H2A, Sm-D antigen, U1-A RNP antigen and 60 kD SSA/Ro antigen were found in 44-95% of HIV-infected patients. Among histone antibodies, the most frequent reactions were towards the carboxy-terminal region of histone H1 and to histone H2B and its amino-terminal domain 1-25. Eight HIV-1-seropositive patients at different stages of disease according to the Centers for Disease Control classification were also studied. In most cases, no obvious fluctuations were observed over several years. Antibodies were found early, and their specificity and apparent level of activity remained relatively constant. There was no evidence of such an autoimmune response in the serum of high-risk homosexual seronegative men.
  
  
  CONCLUSIONS
  Although the aetiology of AIDS is known, in general the aetiology of multisystemic autoimmune diseases remains to be determined, and the sequence of events taking place remains obscure in both cases. It is possible that the large spectrum of antibodies found in HIV-infected patients reflects a specific stimulation of B-cells by nuclear antigens released by apoptosis during an early stage of disease.
authors.affiliation: Immunochemistry Laboratory (UPR 9002-CNRS), Institute of Molecular and Cellular Biology, Strasbourg, France.
authors.forename: S
authors.initials: S
authors.lastname: Muller
authors.forename: P
authors.initials: P
authors.lastname: Richalet
authors.forename: A
authors.initials: A
authors.lastname: Laurent-Crawford
authors.forename: S
authors.initials: S
authors.lastname: Barakat
authors.forename: Y
authors.initials: Y
authors.lastname: Rivière
authors.forename: F
authors.initials: F
authors.lastname: Porrot
authors.forename: S
authors.initials: S
authors.lastname: Chamaret
authors.forename: J P
authors.initials: JP
authors.lastname: Briand
authors.forename: L
authors.initials: L
authors.lastname: Montagnier
authors.forename: A
authors.initials: A
authors.lastname: Hovanessian
mesh_terms: D001323:Autoantibodies / Q000097:blood*; D001327:Autoimmune Diseases / Q000209:etiology / Q000276:immunology*; D004797:Enzyme-Linked Immunosorbent Assay; D015483:HIV Antibodies / Q000276:immunology; D006679:HIV Seropositivity / Q000150:complications / Q000276:immunology*; D006801:Humans; D007074:Immunoglobulin G / Q000276:immunology; D009928:Organ Specificity
chemical_list: D001323:Autoantibodies; D015483:HIV Antibodies; D007074:Immunoglobulin G